It looks as if the VC team has completely taken over Navigenics. Dana Mead of KPCB and Sue Siegel of MDV will be taking over. Mari will stay on as a Board Member.
This whole thing has me wondering........if I pitch an idea to VC, will they turn me down, only to "create" the exact same company? "Oh, we don't sign NDAs"
A lot of Entrepreneurs out there are asking the same questions.....I think they are right to ask these......Despite what they say.....
It seems Navigenics is one of those VC started companies.........and it looks as if they can't pull out.
Why? Well, this seems to be their baby.....Much like Google's baby is 23andME.
Any other sane investor would have pulled out of these companies when the regulations hit. But, now it seems as if these companies are firing their webmasters, outsourcing the work and looking to save face.
What really would hit them hard is if a new round of regulations were to get in their way.....
Many of my detractors say "If these companies die, so does personalized medicine"
I often laugh when I hear this. Is personal genomics the same as personalized medicine?
The short answer is no. The long answer is No Freakin Way!
Most of these markers don't help us at all. The only thing useful here is the social milieu which they are trying to create.
23andME seems to be doing the best job of that. However, with chat rooms filled with medical misinformation, I wonder how useful these sites will become....
The Sherpa Says: Navigenics hasn't fully turned clinical yet........They will once this move is completed and we will have another 2 clinical diagnostic companies that have an undetermined clinical utility. It takes 5 years to prove utility and I think KPCB and MDV are in for the long haul.......Maybe it is the beginning of the end and these guys are just re-arranging deck chairs. Time will tell, Vamos a Ver....
Saturday, February 28, 2009
CDCV, Deck Chairs of the Titanic? We shall see.......
Posted by
Steve Murphy MD
at
10:36 AM
4
comments
Thursday, February 26, 2009
The beginning of the End? Mari leaving Navi?
Mari Baker is leaving Navigenics......
I am fairly certain of that....
Unless you can be the CEO of 2 companies at once.......
"PlayFirst Expands Management Team to Address Growing Consumer Entertainment Market; Recruits Senior Industry Veterans in CEO, CFO Positions
SAN FRANCISCO, Feb. 26 /PRNewswire/ -- PlayFirst, Inc., the award-winning entertainment company, today announced that Mari Baker, a consumer software and internet industry veteran, has been named its Chief Executive Officer. The company also announced today that Jim Wandrey has joined as Chief Financial Officer. PlayFirst, one of the leaders in casual entertainment, recruited the new leadership to address the growing market opportunity in interactive consumer entertainment."
Or maybe they're restructuring. Or maybe a major VC is pulling out???
All the best Mari. I hope your next company doesn't have a multi-million dollar open bar party for 9 days in SoHo.
HT: BC at EG
Posted by
Steve Murphy MD
at
11:43 AM
1 comments
Labels: 23andme, deCODEme, DNA direct, drudgereport, Helix Health of Connecticut, navigenics
Wednesday, February 25, 2009
The Sherpa is Right! DNADirect moves into the clinical space.
Posted by
Steve Murphy MD
at
10:49 AM
4
comments
Labels: 23andme, barack obama, DNA direct, dna dynasty, drudgereport, Helix Health of Connecticut, navigenics
Monday, February 23, 2009
23andME-"Genetic Counseling isn't Clinical Medicine"
Posted by
Steve Murphy MD
at
7:48 AM
18
comments
Labels: 23andme, deCODEme, DNA direct, dna dynasty, Helix Health of Connecticut, navigenics, NSGC
Friday, February 20, 2009
10 months........

Forbes April 2008
"Both 23andMe and DeCode, which has not received a warning letter from New York so far, argue that the lab testing laws don't apply because their products are not medical tests. "23andMe's services are not medical ... they are educational," argues 23andMe spokesman Paul Kranhold. "
"One worry is that people who order online gene tests could get misleading information. For example, 23andMe tests for some gene variants involved in mildly raising breast cancer risk, but not genes called BRCA1 and BRCA2 that vastly raise breast cancer risk. Harvard Medical School's Mark Daley says if you found out that you had genes that slightly reduced the risk of cancer, but didn't check for the real cancer-causing gene like BRCA1, "you get a potentially dangerously misleading answer."
What a difference 10 months makes........
I am certian testing for limited amounts of mutations is probably just as confusing.....
From 23andMe
BRCA Cancer Mutations (Selected)
Breast/Ovarian Cancer is one of the diseases that 23andMe analyzes. Our service includes the following information:
- Whether or not you are a carrier for Breast/Ovarian Cancer.
- Information on SNPs i4000377, i4000378, i4000379, markers that influence your carrier status for Breast/Ovarian Cancer.
- A look at how Breast/Ovarian Cancer works, and a list of counselors, links and support groups for BRCA Cancer Mutations (Selected) in your area.
Carrier for Breast?Ovarian Cancer???? What kind of language is that? One thing is for sure "Carrier for Breast/Ovarian Cancer" sounds an awful lot like genetic risk for breast cancer carrier.......otherwise known as a medical diagnosis code V84.01
It depends on what the meaning of the word "IS" is
The Sherpa Says: Russ, in what world is this something worthy of your support?
Posted by
Steve Murphy MD
at
5:16 PM
1 comments
I am not a man.......
Posted by
Steve Murphy MD
at
4:40 AM
38
comments
Labels: 23andme, deCODEme, drudgereport, Helix Health of Connecticut, navigenics
Wednesday, February 18, 2009
Why Facebook and Not 23andME?
Posted by
Steve Murphy MD
at
7:10 AM
7
comments
Labels: 23andme, A-rod, barack obama, drudgereport, facebook, Helix Health of Connecticut, navigenics, salon



